Lanean...
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
BACKGROUND: Improving outcomes of patients with glioblastoma (GBM) represents a significant challenge in neuro-oncology. We undertook a systematic review of key parameters of phase II and III trials in GBM to identify and quantify the impact of trial design on this phenomenon. METHODS: Studies betwe...
Gorde:
| Argitaratua izan da: | Neurooncol Adv |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850118/ https://ncbi.nlm.nih.gov/pubmed/33543145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa171 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|